CLIN TOXICOL 润色咨询

CLINICAL TOXICOLOGY

出版年份：2005 年文章数：1514 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：15.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1084456, encodeId=850c108445648, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：临床毒理<br>经验分享：多写，多投才能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7e6425449, createdName=ms7000001179532552, createdTime=Sun Dec 26 19:11:56 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497090, encodeId=7f7749e09064, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482351, encodeId=5aa44823511a, content=偏重的研究方向：毒理;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478013, encodeId=d3bb4e8013ee, content=偏重的研究方向：毒理;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=901830830, createdName=cheguowei, createdTime=Wed Jun 29 12:30:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-26 ms7000001179532552

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：临床毒理
    经验分享：多写，多投才能中

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1084456, encodeId=850c108445648, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：临床毒理<br>经验分享：多写，多投才能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7e6425449, createdName=ms7000001179532552, createdTime=Sun Dec 26 19:11:56 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497090, encodeId=7f7749e09064, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482351, encodeId=5aa44823511a, content=偏重的研究方向：毒理;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478013, encodeId=d3bb4e8013ee, content=偏重的研究方向：毒理;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=901830830, createdName=cheguowei, createdTime=Wed Jun 29 12:30:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2013-07-01 gubing035

    这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1084456, encodeId=850c108445648, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：临床毒理<br>经验分享：多写，多投才能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7e6425449, createdName=ms7000001179532552, createdTime=Sun Dec 26 19:11:56 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497090, encodeId=7f7749e09064, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482351, encodeId=5aa44823511a, content=偏重的研究方向：毒理;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478013, encodeId=d3bb4e8013ee, content=偏重的研究方向：毒理;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=901830830, createdName=cheguowei, createdTime=Wed Jun 29 12:30:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 neuron2010

    偏重的研究方向：毒理;

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1084456, encodeId=850c108445648, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：临床毒理<br>经验分享：多写，多投才能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7e6425449, createdName=ms7000001179532552, createdTime=Sun Dec 26 19:11:56 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497090, encodeId=7f7749e09064, content=这个期刊现在2.5分，比去年涨了不少，有没有希望能再上一步？冲到3分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gubing035, createdTime=Mon Jul 01 11:32:00 CST 2013, time=2013-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=482351, encodeId=5aa44823511a, content=偏重的研究方向：毒理;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuron2010, createdTime=Wed Jun 29 17:19:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478013, encodeId=d3bb4e8013ee, content=偏重的研究方向：毒理;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=901830830, createdName=cheguowei, createdTime=Wed Jun 29 12:30:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 cheguowei

    偏重的研究方向：毒理;

    0

共5条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分